An interventional study of filling of Serenat at baseline (T1) and Serenat at baseline T1 and 3 others questionnaires in Adjustment Disorder, sponsored by University Hospital, Lille. Completed at 1 site in France. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-12-22.
Sponsored by University Hospital, Lille · Not applicable, Interventional, and Screening
The main objective of this work is to explore the psychometric properties of scale of well-being at work called "Serenat" in order to validate it. Secondary objectives are to study the influence of socio-demographic characteristics of the subjects on the results of Serenat and to describe the results on subjects monitored among an adult psychiatric population.
This is a cross sectional survey. 200 subjects were selected among people having consulted an occupational doctor to validate the scale in the general population (study 1), and 50 subjects among a psychiatric population for the ancillary study (study 2).
The Serenat Scale is a self-report questionnaire composed of 20 items. All items are scored on a four point Likert scale ranging from 0 (strongly disagree) to 3 (strongly agree) resulting in a range of 0 to 60. The 20 items are related to different domains. 10 items explore psychological balance at work: relaxation (item 1), sleep quality (item 2), concentration (item 3), form (item 4), sense of security (item 5), satisfaction (item 6), quality of relationships and contacts at work (item 7), voltage or aggressiveness (item 8), optimism for the future from a professional point of view (item 9), life balance (item 10). 10 items are related to working conditions and organization of work: comfort of the working environment (item 11), time constraint (item 12), sense of competence (item 13), decision latitude (item 14), interest at work and variety of tasks (item 15), recognition (item 16), professional support (item 17), communication and transfer of information (item 18), human conflict (item 19), satisfactory work schedules (item 20).
63 studies on the registry are indexed under Adjustment Disorders; 13 are open to participants now.
This study's enrollment of 226 is above the median of 100 across 52 interventional studies indexed under Adjustment Disorders.
Browse Adjustment Disorders studies →University Hospital, Lille is the lead sponsor of 631 studies on the registry; 142 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
filling of Serenat at baseline (T1)
Other: filling of Serenat at baseline (T1)
Serenat at baseline T1 and 3 others questionnaires
Other: Serenat at baseline T1 and 3 others questionnaires
filling of Serenat at baseline T1 and T2 (one week after baseline).
Other: filling of Serenat, HADS, STAY-Y and BDI at baseline T1
filling of Serenat, HADS, STAY-Y and BDI at baseline T1
Other: Serenat at baseline T1 and 3 others questionnaires
Patients who consult occupational doctor complete the serenat questionnaire.The time taken to complete the serenat scale is about 5 minutes.
Also known as: filling of Serenat at T1 (baseline)
Subjects who consult occupational doctor complete the 4 questionnaires.The time taken to complete the 4 questionnaires is about 15 minutes.
Also known as: Serenat and 3 others questionnaires at T1
Patients who consult a psychiatrist in a stress anxiety unit complete the 4 questionnaires.
Also known as: filling of Serenat at baseline T1 and T2 (one week later)
Serenat scale
For Group 1, Group 2, Group 3: The Serenat Scale is a self-report questionnaire composed of 20 items. All items are scored on a four point Likert scale ranging from 0 (strongly disagree) to 3 (strongly agree) resulting in a range of 0 to 60. The 20 items are related to different domains. 10 items explore psychological balance at work. 10 items are related to working conditions and organization of work.
Time frame: At baseline (T1)
Serenat scale
For Group 3: The Serenat Scale is a self-report questionnaire composed of 20 items. All items are scored on a four point Likert scale ranging from 0 (strongly disagree) to 3 (strongly agree) resulting in a range of 0 to 60. The 20 items are related to different domains. 10 items explore psychological balance at work. 10 items are related to working conditions and organization of work.
Time frame: one week after baseline (T2)
Hospital Anxiety and Depression Scale (HADS)
For group 2: The scale allows to detect anxiety and depression using 14 items rated from 0-3.
Time frame: At baseline (T1)
State-Trait Anxiety inventory (STAI-Y)
For Group: Self-administered questionnaire of 20 items side on 4 levels from 'not at all' to one side "many" side 4 (total score of 20-80). It measures an intensity of more anxiety and is not related to an anxiety disorder
Time frame: At baseline (T1)
The Beck depression inventory (BDI-21)
For Group, Self-assessment questionnaire measuring the severity of depression
Time frame: At baseline (T1)
Plan to share: Undecided
Ran from Nov 2013 to primary completion in Nov 2017, 48 months.
Of 25 interventional studies with no phase under Adjustment Disorders, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 38. This study's 48 months is above that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.